Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 2 (February)

1. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006.
   Curr Med Res Opin, 24(2): 469-80. [Abstract] [Full-text]
2. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
   Cytokine, 41(2): 84-91. [Abstract] [Full-text]
3. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes.
   Rheumatology (Oxford), 47(3): 301-8. [Abstract] [Full-text]
4. Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice.
   Rheumatology (Oxford), 47(3): 292-300. [Abstract] [Full-text]
5. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.
   Rheumatology (Oxford), 47(3): 339-44. [Abstract] [Full-text]
6. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
   Rheumatology (Oxford), 47(3): 345-9. [Abstract] [Full-text]
7. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
   Rheumatology (Oxford), 47(3): 350-4. [Abstract] [Full-text]
8. Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases and review of the literature.
   Rheumatology (Oxford), 47(3): 315-8. [Abstract] [Full-text]
9. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review.
   Rheumatology (Oxford), 47(3): 239-48. [Abstract] [Full-text]
10. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.
    Rheumatology (Oxford), 47(3): 249-55. [Abstract] [Full-text]
11. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Mol Immunol, 45(7): 1837-46. [Abstract] [Full-text]
12. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
    Ann Rheum Dis, 67(3): 414-7. [Abstract] [Full-text]
13. Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).
    Ann Rheum Dis, 67(3): 315-22. [Abstract] [Full-text]
14. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Ann Rheum Dis, 67(3): 302-8. [Abstract] [Full-text]
15. Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis.
    Ann Rheum Dis, 67(3): 422-4. [Abstract] [Full-text]
16. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
    Ann Rheum Dis, 67(3): 309-14. [Abstract] [Full-text]
17. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
    Ann Rheum Dis, 67(3): 358-63. [Abstract] [Full-text]
18. Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts.
    Ann Rheum Dis, 67(3): 389-94. [Abstract] [Full-text]
19. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
    Ann Rheum Dis, 67(3): 370-4. [Abstract] [Full-text]
20. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Ann Rheum Dis, 67(3): 380-8. [Abstract] [Full-text]
21. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results.
    Ann Rheum Dis, 67(3): 402-8. [Abstract] [Full-text]
22. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Ann Rheum Dis, 67(3): 353-7. [Abstract] [Full-text]
23. Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis.
    Ann Rheum Dis, 67(3): 375-9. [Abstract] [Full-text]
24. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.
    Ann Rheum Dis, 67(3): 409-13. [Abstract] [Full-text]
25. Influence of rheumatoid arthritis on work participation in Australia.
    Intern Med J, 38(3): 166-73. [Abstract] [Full-text]
26. ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy.
    Am J Kidney Dis, 51(3): e11-4. [Abstract] [Full-text]
27. Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experience.
    Radiology, 246(3): 845-53. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.